Several Chinese IVD companies have recently launched strategic cooperation

On April 20, Fapon Biotech Inc. and Guomao Health reached a strategic cooperation intention for IVD ecological open platform. The two parties exchanged views on the future development of the health industry, and reached a consensus on in-depth cooperation, which will jointly help the health industry to build a new pattern. The two sides will give full play to their respective advantages in industry, technology, capital, talents, management, market, resources, etc., carry out in-depth pragmatic cooperation in the field of general health, and achieve common development.

On April 20, the signing ceremony of cooperation between DIAN Diagnostics Group Co., Ltd. and Taizhou Enze Medical Center was held in Taizhou Hospital. The two parties will carry out a new round of strategic cooperation on the basis of the previous cooperation, continue to develop a new model of organic integration of public hospital medical services and third-party medical diagnosis services, and jointly help Taizhou people's health cause.

On April 26, Shenzhen LWPOCT and BIG CO-WIN Fund formally signed a strategic cooperation agreement. In the future, LWPOCT will take CDMO as its main business model to provide customized products and services for in vitro diagnostic and life science instruments, covering the entire life cycle of product development, design & application, product registration, precision manufacturing, and after-sales maintenance.

On May 2, the 100th Anniversary Development Conference of Xiamen University's Biological Discipline was held in Dewang Library of Xiamen University. During the conference, the XMU-Hotgen Biotech Research Centre jointly established by Beijing Hotgen Biotech Co., Ltd. and Xiamen University was officially released, and the unveiling ceremony was held.

Recently, Hangzhou AllTest Biotech Co., Ltd. and Zhejiang Zhende Health Technology Co., Ltd., held a strategic cooperation agreement signing ceremony in Shaoxing. The two sides will cooperate on SARS-CoV-2 antigen detection kits to help prevent and control the epidemic.